(S)-1-(4-((S)-2-allyl-4,5-dihydro-1H-imidazol-4-yl)butyl)-4-benzyl-3-phenethylimidazolidine-2-thione

ID: ALA4073023

PubChem CID: 137640324

Max Phase: Preclinical

Molecular Formula: C28H36N4S

Molecular Weight: 460.69

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCC1=N[C@@H](CCCCN2C[C@H](Cc3ccccc3)N(CCc3ccccc3)C2=S)CN1

Standard InChI:  InChI=1S/C28H36N4S/c1-2-11-27-29-21-25(30-27)16-9-10-18-31-22-26(20-24-14-7-4-8-15-24)32(28(31)33)19-17-23-12-5-3-6-13-23/h2-8,12-15,25-26H,1,9-11,16-22H2,(H,29,30)/t25-,26-/m0/s1

Standard InChI Key:  SMZBJNNJLBYYFH-UIOOFZCWSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   13.0401  -18.2719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2634  -18.5260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0950  -19.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3183  -19.5797    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0687  -20.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2515  -20.3585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9975  -19.5817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6577  -19.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6567  -18.2831    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.2198  -19.3307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6135  -19.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8304  -19.6303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5508  -21.0168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2204  -21.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4076  -21.8464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0772  -22.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5594  -23.2538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3758  -23.1632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7025  -22.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6454  -18.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4215  -18.5680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5905  -17.7676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9772  -17.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2035  -17.4775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2270  -20.1814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4480  -19.9345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1861  -19.1619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3690  -19.1678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1220  -19.9468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7866  -20.4223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3466  -20.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7354  -19.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9601  -19.9207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
  5 13  1  1
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  1 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24  1  1  0
 12 25  1  0
 26 25  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4073023

    ---

Associated Targets(Human)

RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorb Nuclear receptor ROR-beta (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.69Molecular Weight (Monoisotopic): 460.2661AlogP: 4.86#Rotatable Bonds: 12
Polar Surface Area: 30.87Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.06CX LogP: 5.46CX LogD: 3.23
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: -0.09

References

1. Nefzi A, Marconi GD, Ortiz MA, Davis JC, Piedrafita FJ..  (2017)  Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs).,  27  (7): [PMID:28242276] [10.1016/j.bmcl.2017.02.014]

Source